<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab5">
 <label>Table 71.5</label>
 <caption>
  <p>Representative studies of oseltamivir and zanamivir susceptibility of field isolates of influenza A and B viruses</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Study</th>
    <th>Location</th>
    <th>Seasons</th>
    <th>Assay</th>
    <th>No. tested</th>
    <th>No. (%) resistant</th>
    <th>Mutations detected</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="3">McKimm-Breschkin et al. [
     <xref ref-type="bibr" rid="CR214">215</xref>]
    </td>
    <td rowspan="3">Worldwide</td>
    <td rowspan="3">1999–2002</td>
    <td rowspan="3">NAI-FA, NAI-CL, S</td>
    <td>139 A/N1</td>
    <td>0</td>
    <td rowspan="3"/>
   </tr>
   <tr>
    <td>767 A/N2</td>
    <td>0</td>
   </tr>
   <tr>
    <td>148 B</td>
    <td>0</td>
   </tr>
   <tr>
    <td rowspan="3">Hurt et al. [
     <xref ref-type="bibr" rid="CR215">216</xref>]
    </td>
    <td rowspan="3">Australia, Southeast Asia</td>
    <td rowspan="3">1998–2002</td>
    <td rowspan="3">NAI-FA</td>
    <td>235 A/N1</td>
    <td>0</td>
    <td rowspan="3"/>
   </tr>
   <tr>
    <td>169 A/N2</td>
    <td>0</td>
   </tr>
   <tr>
    <td>128 B</td>
    <td>0
     <sup>a</sup>
    </td>
   </tr>
   <tr>
    <td rowspan="3">Bovin and Goyette [
     <xref ref-type="bibr" rid="CR216">217</xref>]
    </td>
    <td rowspan="3">Canada</td>
    <td rowspan="3">1999–2000</td>
    <td rowspan="3">NAI-CL</td>
    <td>38 H3N2</td>
    <td>0</td>
    <td rowspan="3"/>
   </tr>
   <tr>
    <td>40 H2N1</td>
    <td>0</td>
   </tr>
   <tr>
    <td>23 B</td>
    <td>0</td>
   </tr>
   <tr>
    <td rowspan="3">Mungall et al. [
     <xref ref-type="bibr" rid="CR217">218</xref>]
    </td>
    <td rowspan="3">Worldwide</td>
    <td rowspan="3">2000–2002</td>
    <td rowspan="3">NAI-CL</td>
    <td>567 A/N2</td>
    <td>0</td>
    <td rowspan="3"/>
   </tr>
   <tr>
    <td>271 A/N1</td>
    <td>0</td>
   </tr>
   <tr>
    <td>712 B</td>
    <td>0</td>
   </tr>
   <tr>
    <td rowspan="3">Monto et al. 2006 [
     <xref ref-type="bibr" rid="CR143">143</xref>]
    </td>
    <td rowspan="3">Worldwide</td>
    <td rowspan="3">1999–2002</td>
    <td rowspan="3">NAI-CL, S</td>
    <td>922 A/N2</td>
    <td>3 (0.3 %)</td>
    <td>Gln41Gly, Gln226His</td>
   </tr>
   <tr>
    <td>622 A/N1</td>
    <td>3 (0.5 %)</td>
    <td>His274Tyr, Tyr155His, Gly248Arg</td>
   </tr>
   <tr>
    <td>743 B</td>
    <td>2 (0.3 %)</td>
    <td>Asp198Glu, Ile222Thr</td>
   </tr>
   <tr>
    <td>Ferraris et al. [
     <xref ref-type="bibr" rid="CR218">219</xref>]
    </td>
    <td>France</td>
    <td>2002–2005</td>
    <td>NAI-FA, S</td>
    <td>788 H3N2</td>
    <td>0
     <sup>b</sup>
    </td>
    <td/>
   </tr>
   <tr>
    <td rowspan="2">NISN WER [
     <xref ref-type="bibr" rid="CR219">220</xref>]
    </td>
    <td rowspan="2">Japan</td>
    <td rowspan="2">2003–2004</td>
    <td rowspan="2">NAI-CL, S</td>
    <td>1180 H3N2</td>
    <td>3 (0.3 %)</td>
    <td rowspan="2">2 Glu119Val, 1 Arg292Lys</td>
   </tr>
   <tr>
    <td>171 B</td>
    <td>0</td>
   </tr>
   <tr>
    <td>Hatakeyama et al. [
     <xref ref-type="bibr" rid="CR220">221</xref>]
    </td>
    <td>Japan</td>
    <td>2004–2005</td>
    <td>NAI-FA, S</td>
    <td>422 B</td>
    <td>7 (1.7 %)</td>
    <td>3 Asp198Asn, 3 Ile222Thr, 1 Ser250Gly</td>
   </tr>
   <tr>
    <td rowspan="4">NISN WER [
     <xref ref-type="bibr" rid="CR221">222</xref>]
    </td>
    <td rowspan="4">Japan</td>
    <td>2004–2005</td>
    <td>NAI-CL, S</td>
    <td>558 H3N2</td>
    <td>0</td>
    <td rowspan="4">4 His274Tyr</td>
   </tr>
   <tr>
    <td rowspan="3">2005–2006</td>
    <td rowspan="3">S</td>
    <td>60 H1N1</td>
    <td>0</td>
   </tr>
   <tr>
    <td>251 H3N2</td>
    <td>0</td>
   </tr>
   <tr>
    <td>178 H1N1</td>
    <td>4</td>
   </tr>
   <tr>
    <td rowspan="4">Whitley et al. [
     <xref ref-type="bibr" rid="CR103">103</xref>]
    </td>
    <td rowspan="4">Worldwide</td>
    <td rowspan="4">2009–2013</td>
    <td rowspan="4">NAI-CL, S, PCR</td>
    <td>335 H3N2</td>
    <td>0</td>
    <td rowspan="4">47 His274Tyr</td>
   </tr>
   <tr>
    <td>47 sH1N1</td>
    <td>100</td>
   </tr>
   <tr>
    <td>889 2009H1N1</td>
    <td>0</td>
   </tr>
   <tr>
    <td>518 B</td>
    <td>0</td>
   </tr>
   <tr>
    <td rowspan="3">Meijer et al. [
     <xref ref-type="bibr" rid="CR121">121</xref>]
    </td>
    <td rowspan="3">Worldwide</td>
    <td rowspan="3">2012–2013</td>
    <td rowspan="3">NAI-FA, S</td>
    <td>2343 H1N1</td>
    <td>18 (&lt;0.1 %)</td>
    <td>18 His274Tyr</td>
   </tr>
   <tr>
    <td>5109 H3N2</td>
    <td>4 (&lt;0.1 %)</td>
    <td>3 Glu119Val, 1 Arg292Lys</td>
   </tr>
   <tr>
    <td>3935 B</td>
    <td>2 (&lt;0.1 %)</td>
    <td>2 His273Tyr</td>
   </tr>
   <tr>
    <td rowspan="3">Takashita et al. [
     <xref ref-type="bibr" rid="CR106">106</xref>]
    </td>
    <td rowspan="3">Worldwide</td>
    <td rowspan="3">2013–2014</td>
    <td rowspan="3">NAI-FA, S</td>
    <td>5152 H1N1</td>
    <td>169 (3.3 %)</td>
    <td>169 His274Tyr</td>
   </tr>
   <tr>
    <td>2574 H3N2</td>
    <td>1 (&lt;0.1 %)</td>
    <td>1 Glu119Val</td>
   </tr>
   <tr>
    <td>2915 B</td>
    <td>1 (&lt;0.1 %)</td>
    <td>1 His273Tyr</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>Abbreviations</italic>: 
   <italic>NAI</italic> neuraminidase inhibition, 
   <italic>CL</italic> chemiluminescence, 
   <italic>FA</italic> fluorescence, 
   <italic>S</italic> sequence analysis of neuraminidase gene, 
   <italic>PCR</italic> polymerase chain reaction
  </p>
  <p>
   <sup>a</sup>One B/Perth/211/2001 isolate had ninefold reduced susceptibility to zanamivir and 14-fold to oseltamivir compared to the mean inhibitory concentrations of influenza B strains and contained a mixed population including resistant variants with a Asp197Glu mutation [
   <xref ref-type="bibr" rid="CR79">79</xref>]
  </p>
  <p>
   <sup>b</sup>Four isolates (0.5 %) with NA deficiency were found to be resistant to NA inhibitors in cell culture-based assays
  </p>
 </table-wrap-foot>
</table-wrap>
